SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007686
Filing Date
2019-08-08
Accepted
2019-08-08 16:02:11
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20190630x10q.htm 10-Q 1370975
2 EX-10.1 mrns-20190630ex1012ca690.htm EX-10.1 109462
3 EX-31.1 mrns-20190630ex3111b11dc.htm EX-31.1 15196
4 EX-31.2 mrns-20190630ex312756236.htm EX-31.2 15376
5 EX-32.1 mrns-20190630ex321b5f68c.htm EX-32.1 9445
6 GRAPHIC mrns20190630x10q001.jpg GRAPHIC 23678
7 GRAPHIC mrns20190630x10q002.jpg GRAPHIC 116855
  Complete submission text file 0001558370-19-007686.txt   4164327

Data Files

Seq Description Document Type Size
8 EX-101.INS mrns-20190630.xml EX-101.INS 679588
9 EX-101.SCH mrns-20190630.xsd EX-101.SCH 22391
10 EX-101.CAL mrns-20190630_cal.xml EX-101.CAL 39067
11 EX-101.DEF mrns-20190630_def.xml EX-101.DEF 77675
12 EX-101.LAB mrns-20190630_lab.xml EX-101.LAB 255266
13 EX-101.PRE mrns-20190630_pre.xml EX-101.PRE 173983
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 191009411
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences